Synthesis and Anti-hepatitis B Virus Activity of Novel Benzimidazole Derivatives
Overview
Authors
Affiliations
A series of novel benzimidazole derivatives was synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in vitro. Strong activity against HBV replication and low cytotoxicity were generally observed in these benzimidazoles. The most promising compounds were 12a and 12b, with similar high antiviral potency (IC50 = 0.9 and 0.7 microM, respectively) and remarkable selectivity indices (>1111 and 714, respectively). They were selected for further evaluation as novel HBV inhibitors.
Khushal A, Farooq U, Khan S, Rasul A, Wani T, Zargar S Molecules. 2023; 28(18).
PMID: 37764324 PMC: 10538174. DOI: 10.3390/molecules28186548.
DDQ in mechanochemical C-N coupling reactions.
Kanti Bera S, Bhanja R, Mal P Beilstein J Org Chem. 2022; 18:639-646.
PMID: 35706992 PMC: 9174842. DOI: 10.3762/bjoc.18.64.
ILDR1 promotes influenza A virus replication through binding to PLSCR1.
Liu Y, Lin S, Xie Y, Zhao L, Du H, Yang S Sci Rep. 2022; 12(1):8515.
PMID: 35595813 PMC: 9122930. DOI: 10.1038/s41598-022-12598-3.
Huynh T, Nguyen T, Nguyen T, Hoang T RSC Adv. 2022; 10(35):20543-20551.
PMID: 35517717 PMC: 9054280. DOI: 10.1039/d0ra02282a.
Abdel-Maksoud M, Mohamed A, Hassan R, Abdelgawad M, Chilingaryan G, Selim S Int J Mol Sci. 2021; 22(19).
PMID: 34638829 PMC: 8508980. DOI: 10.3390/ijms221910491.